2024
Provider Experience With the Use of Ketamine for Refractory Status Epilepticus
Tantillo G, Davis N, Granstein J, Yoo J, Agarwal P, Reilly K, Reynolds A, Kayal G, Liang J, Jetté N. Provider Experience With the Use of Ketamine for Refractory Status Epilepticus. Clinical Neuropharmacology 2024, 47: 37-43. PMID: 38478363, DOI: 10.1097/wnf.0000000000000582.Peer-Reviewed Original ResearchConceptsRefractory status epilepticusStatus epilepticusPerceived contraindicationsUse of vasopressorsFirst-line agentsRefractory status epilepticus treatmentSecond-line agentsAssociated with complicationsElevated intracranial pressureNeurocritical Care SocietyRespiratory depressionHeart failureEEG monitoringHemodynamic supportOptimal doseKetamine useSeizure controlIntracranial pressureControl seizuresDecreased needKetamine usersAmerican Epilepsy SocietyKetamineAmerican AcademyAnesthetic agents
2019
Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE) (P5.5-032)
Wong B, Yoo J, Fields M. Early Use of Vagal Nerve Stimulation (VNS) in a Patient with New Onset Refractory Status Epilepticus (NORSE) (P5.5-032). Neurology 2019, 92 DOI: 10.1212/wnl.92.15_supplement.p5.5-032.Peer-Reviewed Original Research